Ready to Learn from My Mentors? Book a Free Strategy Call at https://felixfriends.org/freedom
5 extracted signals · 5 resolved · 0 still active
Felix & Friends (Goat Academy)Independent analyst profile- Source published
- 10 Nov 2025, 19:15 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
AI-generated source summary
The video identifies five stocks - A (Agilent Technologies), XOM (Exxon Mobil Corporation), TXG (10x Genomics), DNUT (Krispy Kreme, Inc.), and ZYME (Zymeworks Inc.) - across five different sectors. November is pivotal due to breakthroughs in AI healthcare, energy companies' cash printing, and scientific advancements. A is called an invisible giant powering modern medicine, market growing 7% per year with estimates of US market reaching $269 billion by 2034. It's driven by personalized medicine, pharmaceutical R&D spending, and AI. It is selling the equipment into all of these bio tech companies. Its market is a 52% gross margin; 14.23% ROIC; 16% free cash flow; . In the chart he pointed to a new area around $148. Exxon is trading at about $117, they have massive oil reserves, but he notes analysts say to hold, with a PE ratio of 15.7, but says a lot of money goes back to share holders. Krispy Kreme is at about $4, and he notes that revenue is down due to intentional close downs of stores to streamline profits, to around $40 million. ZYME is at around $16.00, its in clinical stage, and he looks at ADC's in that area.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
5 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Felix & Friends (Goat Academy)
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.